Lumefantrine co-amorphous systems using deoxycholic acid as a co-former: NIR at-line process monitoring by machine learning

Graphical Abstract This is a visual representation of the abstract. Background Various methods have been reported for improving the water-insoluble drugs in oral administration formulations. Among them, amorphization has been attracting attention and developed as a method for solubilizing API (active pharmaceutical ingredient)s by changing their physicochemical properties. Molecular complexation is also known as a method for solubilizing APIs by synthesizing cocrystals, etc. Co-amorphization, which achieves both molecular complexation and amorphization, is effective and has attracted attention. Thus, co-amorphization has been proven to be an effective approach to solubilization. Objective This study aims to improve the solubility of lumefantrine, used here as a model compound, through co-amorphization with deoxycholic acid. Significance The physicochemical properties are an important factor in developing pharmaceutical ingredients. Hydrogen-bonded co-amorphization has gained attention as a method to enhance the physicochemical properties of hydrophobic drugs. Methods The co-amorphous Lumefantrine-deoxycholic acid system was prepared using a mechanochemical synthesis method based on ball milling. The synthesis process was monitored by powder X-ray diffraction and near-infrared spectroscopy. The products and materials were analyzed by thermal analysis. Results Spectroscopic analysis revealed that the two molecules were complexed through intermolecular hydrogen bonding interactions. The produced co-amorphous has no melting point was found by thermal analysis. Conclusions Process monitoring also indicated the presence of a metastable crystalline Lumefantrine (LMF) intermediate.

• Publication year

  2025

• Venue

  Bio-medical materials and engineering

• Publication date

  2025-08-04

• Fields of study

  Medicine, Materials Science, Chemistry, Engineering

• Identifiers
  DOI 10.1177/09592989251353457PMID 40760872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development and characterization of co-amorphous griseofulvin/L-leucin by modified solvent processing hot-melt extrusion.

  2024cited by this paper
• Introduction to Pharmaceutical Co-amorphous Systems Using a Green Co-milling Technique

  2023cited by this paper
• Influence of Co-amorphization on the Physical Stability and Dissolution Performance of an Anthelmintic Drug Flubendazole.

  2023cited by this paper
• Lumefantrine solid dispersions with piperine for the enhancement of solubility, bioavailability and anti-parasite activity.

  2022cited by this paper
• Solid Dispersion of Lumefantrine Using Soluplus® by Solvent Evaporation Method: Formulation, Characterization and in-vitro Antimalarial Screening

  2022cited by this paper
• Role of Hydrogen Bonds in Formation of Co-amorphous Valsartan/Nicotinamide Compositions of High Solubility and Durability with Anti-hypertension and Anti-COVID-19 Potential

  2021cited by this paper
• Effect of mechanochemical grinding conditions on the formation of pharmaceutical cocrystals and co-amorphous solid forms of ketoconazole – Dicarboxylic acid

  2021cited by this paper
• The Effect of Cis and Trans Butenedioic Acid on the Physicochemical Behavior of Lumefantrine

  2021cited by this paper
• Singular value decomposition analysis of the secondary structure features contributing to the circular dichroism spectra of model proteins

  2021cited by this paper
• Dry mechanochemical synthesis of ethenzamide and saccharin 1:1 cocrystal and their evaluation using powder X-ray diffraction and FT-IR and NIR spectroscopy

  2021cited by this paper
• Amorphous drug-polymer salt with high stability under tropical conditions and fast dissolution: The challenging case of lumefantrine-PAA.

  2021cited by this paper
• Effects of heat treatment on indomethacin-cimetidine mixture; Investigation of drug-drug interaction using singular value decomposition in FTIR spectroscopy.

  2020cited by this paper
• Lumefantrine Comparative Study: Single Crystal, Powder X-Ray Diffraction, Hirshfeld Surface, and Thermal Analysis

  2020cited by this paper
• Effect of Polymers and Storage Relative Humidity on Amorphous Rebamipide and Its Solid Dispersion Transformation: Multiple Spectra Chemometrics of Powder X-Ray Diffraction and Near-Infrared Spectroscopy

  2020influential reference
• Green Analytical Methods of Antimalarial Artemether-Lumefantrine Analysis for Falsification Detection Using a Low-Cost Handled NIR Spectrometer with DD-SIMCA and Drug Quantification by HPLC

  2020cited by this paper
• Preparation and Characterization of Solid Dispersions Composed of Curcumin, Hydroxypropyl Cellulose and/or Sodium Dodecyl Sulfate by Grinding with Vibrational Ball Milling

  2020cited by this paper
• Formulation development and characterization of lumefantrine nanosuspension for enhanced antimalarial activity

  2020cited by this paper
• Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation

  2020cited by this paper
• Effects of polymer molecular weight on curcumin amorphous solid dispersion; at-line monitoring system based on attenuated total reflectance mid-infrared and near-infrared spectroscopy

  2020cited by this paper
• ENHANCEMENT SOLUBILITY AND DISSOLUTION RATE OF PARACETAMOL AND IBUPROFEN BY COAMORPHOUS PARTICLES USING MICROWAVE TECHNIQUE

  2019cited by this paper
• Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form

  2017cited by this paper
• Powder grinding preparation of co-amorphous β-azelnidipine and maleic acid combination: Molecular interactions and physicochemical properties

  2016cited by this paper
• Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products.

  2015cited by this paper
• Drug–Drug Coamorphous Systems: Characterization and Physicochemical Properties of Coamorphous Atorvastatin with Carvedilol and Glibenclamide

  2013cited by this paper
• Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.

  2012cited by this paper
• Chapter 22 - Singular Value Decomposition in Active Monitoring Data Analysis

  2010cited by this paper
• Cocrystal or salt: does it really matter?

  2007cited by this paper
• Pharmaceutical Applications of Hot-Melt Extrusion: Part I

  2007cited by this paper
• Supercritical carbon dioxide treatment as a method for polymorph preparation of deoxycholic acid.

  2003cited by this paper
• NIR spectroscopy: a rapid-response analytical tool

  2002cited by this paper
• Identification of pharmaceutical excipients using NIR spectroscopy and SIMCA.

  1999cited by this paper
• EXAFS and FTIR studies on the binding of deoxycholic acid with copper and zinc ions

  1995cited by this paper

• No citing papers are available for this paper.